Nicholas Investment Partners portfolio
Type not verifiedPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 14, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Nicholas Investment Partners reported a $1.6 bn portfolio of 175 positions to the SEC as of the end of Q2 2026. Its largest positions are BWXT, RVMD, CALY. During the quarter it opened Kontoor Brands and Rhythm Pharmaceuticals and exited Kratos Defense & Security Solutions and Embraer.
Sections with a free account
What changed this quarter
185 positions with a change (38 new, 70 added to, 38 trimmed, 39 sold); also, 2 exited through an acquisition or merger. 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Kratos Defense & Security Solutions−1.8 ppof portfolioSold out2.3% → —
- Embraer−1.6 ppof portfolioSold out2.1% → —
- Kontoor Brands+1.4 ppof portfolioNew— → 1.4%
- Insmed−86%fewer sharesReduced2.4% → 0.2%
- Sterling Infrastructure−39%fewer sharesReduced1.7% → 1.6%
- Nuvalent−95%fewer sharesReduced1.3% → 0.1%
- Callaway Golf+74%more sharesIncreased1.3% → 2.4%
- Rhythm Pharmaceuticals+1.0 ppof portfolioNew— → 1.0%
- Bloom Energy−99%fewer sharesReduced1.2% → under 0.1%
- Life Time Group Holdings+0.9 ppof portfolioNew— → 0.9%
- Dianthus Therapeutics+264%more sharesIncreased0.4% → 1.2%
- Cytokinetics+199%more sharesIncreased0.4% → 1.1%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- BWX TechnologiesBWXT3.4%
- Revolution MedicinesRVMD3.0%
- Callaway GolfCALY2.4%
- Modine ManufacturingMOD1.9%
- Carpenter TechnologyCRS1.7%
- Lincoln Educational ServicesLINC1.7%
- NVIDIANVDA1.6%
- Sterling InfrastructureSTRL1.6%
- Axsome TherapeuticsAXSM1.6%
- GE VernovaGEV1.6%
- Xenon PharmaceuticalsXENE1.5%
- BridgeBio PharmaBBIO1.5%
- Lattice SemiconductorLSCC1.4%
- Kontoor BrandsKTB1.4%
- Taiwan Semiconductor ManufacturingTSM1.4%
Portfolio by sector
- ● Information Technology 27%
- ● Industrials 18%
- ● Health Care 18%
- ● Consumer Discretionary 15%
- ● Financials 6%
- ● Energy 5%
- ● Real Estate 3%
- ● Materials 3%
- ● Consumer Staples 3%
- ● Communication Services 2%
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Type not verified: we have not assigned a type because we found no document that is enough to tell. Most 13F filers are in this situation: we only review in depth those that meet the portfolio criteria.
Not counted as a concentrated manager: its portfolio is not within 5 to 100 positions; its top 10 positions are under 45%. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- Heitman Real Estate SecuritiesInvestment firm · $1.6 bn
- QVT FinancialInvestment firm · $1.5 bn
- Dorsey Asset ManagementInvestment firm · $1.6 bn
- Stony Point CapitalInvestment firm · $1.5 bn
- Cryder Capital Partners LLPInvestment firm · $1.6 bn
- Kontiki Capital Management (HK)Investment firm · $1.5 bn